
Journal of Medicinal Chemistry p. 2047 - 2051 (1987)
Update date:2022-08-04
Topics:
Kaminski, James J.
Perkins, D. G.
Frantz, J. D.
Solomon, Daniel M.
Elliott, Arthur J.
et al.
Investigation of the interrelationship between structure, antiulcer activity, and toxicology screening data derived from a series of compounds selected from structure-activity studies directed toward identifying a successor to 3-(cyanomethyl)-2-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyridine, Sch 28080 (1), has identified 3-(cyanomethyl)-2,7-dimethyl-8-(phenylmethoxy)imidazo<1,2-a>pyridine (5), 3-amino-2-methyl-8-(2-phenylethyl)imidazo<1,2-a>pyridine (6), and 3-amino-2-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyrazine (7).These analogues exhibit a combination of antisecretory and cytoprotective activity in animal models, while eliminating the adverse effects of the prototype 1.One of these, 3-amino-2-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyrazine, Sch 32651 (7), has a profile meeting all criteria.
View MoreTaizhou KEDE Chemical.Co.,Ltd.
Contact:86-576-84613060
Address:Jiangkou Chemical Zoon
Contact:(86) 731 88718666
Address:Room 1222, Unit 4, Building B, Shangcheng, No.47, Kaiyuan East Road.
Contact:+86 512 6287 2180
Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Shijiazhuang Haotian Chemical Co., Ltd.
Contact:86-311-85044374
Address:293 Donggang Road
Wuhan Shangrisyn chemicals Technology Co.,Ltd(expird)
Contact:+86-027-84466317 __ +86-15387123698
Address:wuhan - china
Doi:10.1021/jo00086a016
(1994)Doi:10.1021/jf035008h
(2004)Doi:10.1021/acs.joc.1c01124
(2021)Doi:10.1021/ja00254a051
(1987)Doi:10.1039/jr9500001510
(1950)Doi:10.1248/cpb.34.4443
(1986)